Low-dose aspirin does not prevent preeclampsia in high-risk women, study finds.
This article was originally published in The Tan Sheet
Executive Summary
LOW-DOSE ASPIRIN DOES NOT PREVENT PREECLAMPSIA IN HIGH-RISK WOMEN in a 2,503-subject study, Steve Caritis, MD, University of Pittsburgh, et al., report in the March 12 New England Journal of Medicine. The incidence of preeclampsia was 18% among the 1,254 high-risk women in the 60 mg low-dose aspirin group and 20% in the 1,249 high-risk women placebo group, leading the researchers to conclude low-dose aspirin does not provide a significant reduction in preeclampsia. Aspirin also did not improve perinatal outcomes in women at high risk for preeclampsia, the researchers say.